SUSAN B ANTHONY LIST
Registrant: SUSAN B ANTHONY LIST
Reported lobbying issue
Family issues/Abortion/Adoption: H.R. 1 One Big Beautiful Bill Act; H.R.2557 IVF For Military Families Act; S.2035 Protect IVF Act; S.1882, H.R.3589 RESTORE Act; Shield laws; Chemical abortion drugs; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; H.R. 5485 Second Chance at Life Act of 2025; S.2418 HEALING Mothers and Fathers Act; S.2433 Neonatal Care Transparency Act of 2025; H.Res.611 Expressing the importance of accurate information for medical professionals treating pregnant women and their unborn children in the emergency department, and for informing the general public, and for other purposes; S.2955 A bill to amend title 18, United States Code, to establish Federal penalties for the knowing and intentional administration of any abortion-inducing drug to a woman without her informed consent, if the abortion-inducing drug has been shipped or transported in interstate commerce, and for other purposes; Patient Protection and Affordable Care Act; Abortion funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S. 5371 Continuing Appropriations and Extensions Act, 2026; Contraception issues; IVF issues; National Defense Authorization Act; Supreme Court Decisions; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631, H. R. 5646 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions Health Issues: H.R. 1 One Big Beautiful Bill Act; S.1882, H.R.3589 RESTORE Act; Shield Laws; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; S.2418 HEALING Mothers and Fathers Act; S.2433 Neonatal Care Transparency Act of 2025; H.Res.611 Expressing the importance of accurate information for medical professionals treating pregnant women and their unborn children in the emergency department, and for informing the general public, and for other purposes; Patient Protection and Affordable Care Act; Contraception Issues; National Defense Authorization Act; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; Administration Personnel and Judicial Nominees; Presidential Administration Actions Medical/Disease Research/Clinical Labs: H.R. 1 One Big Beautiful Bill Act; S.1882, H.R.3589 RESTORE Act; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; H.R.2075, S.987 Protecting Life and Integrity in Research Act of 2025; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; H.R. 685 Support and Value Expectant Moms and Babies Act; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; IVF Issues; Administration Personnel and Judicial Nominees; Presidential Administration Actions Insurance: H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Patient Protection and Affordable Care Act; Abortion Funding; Contraception Issues; IVF Issues; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S. 5371 Continuing Appropriations and Extensions Act, 2026 Medicare/Medicaid: H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Patient Protection and Affordable Care Act; Contraception Issues; Supreme Court Decisions; Presidential Administration Actions Pharmacy: Shield Laws; Chemical abortion drugs; Supreme Court Decisions; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631 Restoring Safeguards for Dangerous Abortion Drugs Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions Foreign Relations: H.R. 2706 Aid Accountability Act of 2025; Presidential Administration Actions Budget/Appropriations: H.R. 1 One Big Beautiful Bill Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Patient Protection and Affordable Care Act; Abortion Funding; S. 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S. 5371 Continuing Appropriations and Extensions Act, 2026; Administration Personnel and Judicial Nominees Civil Rights/Civil Liberties: Supreme Court Decisions Constitution: Supreme Court Decisions Veterans: Administration Personnel and Judicial Nominees; Presidential Administration Actions Defense: Presidential Administration Actions; H.R.2557 IVF For Military Families Act; National Defense Authorization Act Taxation/Internal Revenue Code: S.2418 HEALING Mothers and Fathers Act Government Issues: Presidential Administration Actions District of Columbia: Presidential Administration Actions Law Enforcement/Crime/Criminal Justice: Dismemberment Abortion Ban Act; H.R. 4964 Child Interstate Abortion Notification Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions; S.2955 A bill to amend title 18, United States Code, to establish Federal penalties for the knowing and intentional administration of any abortion-inducing drug to a woman without her informed consent, if the abortion-inducing drug has been shipped or transported in interstate commerce, and for other purposes. Housing: Presidential Administration Actions Transportation: Presidential Administration Actions
Government entities reported: HOUSE OF REPRESENTATIVES SENATE White House Office
Reported filing-period amount: $360,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.






































































